openPR Logo
Press release

Antisense Oligonucleotides Market Report 2017 – 2027: By Application

11-30-2017 10:47 AM CET | Health & Medicine

Press release from: Future Market Insights

Antisense Oligonucleotides Market Report 2017 – 2027:

Antisense oligonucleotides (ASOs) are 15–25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein. ASOs offers promising treatment options for a range of medical disorders. They facilitate the development of therapeutics affecting protein targets which cannot be treated with protein therapeutics. They can target a particular malfunctioning gene, interfere with RNA function at cellular level, and can also be silenced or modulated. It allows modifications in immune system that facilitates treatment of a wide range of autoimmune disorders – that cannot be treated with available drugs. It is easy to scale up the commercial scale GMP production of these oligonucleotides compared to other biologic therapies. Moreover, the side effects of antisense oligonucleotides are minimal and can be controlled with ease as compared to other class of drugs.

Read Report Overview @ https://www.futuremarketinsights.com/reports/antisense-oligonucleotides-market

Though, the antisense oligonucleotides market has witnessed four FDA approvals [fomivirsen (Vitravene) approved in 1998 – which was discontinued due to low demand; pegaptanib (Macugen) in 2004; mipomersen (Kynamro) in 2013; and eteplirsen (Exondys 51) in 2016). However, this market is yet to achieve recognition as a valuable drug category like biologics, small molecules, and gene and cell therapy. However, in December 2016, this was projected to change with the approval of nusinersen (Spinraza) for treating spinal muscular atrophy (SMA), which is one of the most common genetic cause for infant mortality with no approved treatments. Spinraza has shown unprecedented results for the treatment of SMA in clinical trials.

Strong pipeline of antisense oligonucleotides and increased focused on large number of product approvals and commercialization are some of the primary factors driving the growth of the global antisense oligonucleotides market. Moreover, significant advances in the field of antisense oligonucleotides at a therapeutic or clinical level is further contributing to the growth of the global antisense oligonucleotides market. However, the global antisense oligonucleotides market is grappling with numerous challenges related to diversity of oligonucleotides, delivery, and regulatory complexity. Despite several advancements at clinical levels, the delivering of active oligonucleotide to the actual site within target cells is still one of the major challenges hindering the growth of the global antisense oligonucleotides market. In addition to this, developing a new set of unique regulatory guidelines is another challenge limiting the growth of the global antisense oligonucleotides market.

Although the development of oligonucleotide therapeutics commenced in 1970s, FDA has approved only four oligonucleotide drugs (of which fomivirsen was discontinued) nearly a half century later. However, the filed is gaining momentum and is set to offer promising growth opportunities with a strong pipeline of 135 oligonucleotides in various stages of clinical trials. Even when the market performance of antisense oligonucleotides is not predictable as like other segments of the industry, the future looks very promising primarily reflected by the leadings players in the market and the amount of research and development investments.

Geographically, the global antisense oligonucleotides market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America clearly dominates the global antisense oligonucleotides market due to a strong product pipeline and increasing number of FDA approvals in the region.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5377

Some of the players identified in the global antisense oligonucleotides market include Ionis Pharmaceuticals, Inc., Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Inc., Antisense Therapeutics Limited, Isarna Therapeutics GmbH, Arrowhead Pharmaceuticals, Inc., Atlantic Pharmaceuticals, Inc., Enzon Pharmaceuticals, Inc., Bio-Path Holdings, Inc., Gene Signal International SA, GlaxoSmithKline plc, Geron Corporation, Gradalis, ICO Therapeutics, Aptose Biosciences, Marina Biotech, miRagen Therapeutics, Inc., Synlogic, Inc., OncoGenex Pharmaceuticals Inc., Pharmaxis Ltd, Regulus Therapeutics Inc., Rexahn Pharmaceuticals, Inc., and RXi Pharmaceuticals, among others.

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antisense Oligonucleotides Market Report 2017 – 2027: By Application here

News-ID: 839196 • Views: 269

More Releases from Future Market Insights

The German Tortilla Mix Market is estimated to grow at a CAGR of 4.7% by 2023 to …
In 2023, the market share of tortilla mix was estimated to be worth US$ 12.23 billion. By 2033, it was estimated to be worth US$ 23.18 billion. This is expected to further boost the market share of the tortilla mix and generate a CAGR of 6.6%. The nutritional benefits of tortillas have become increasingly popular in both developed and developing countries. At the same time, a growing number of people are
Asian pacific Sheep Shearing Equipment Market was valued at US$ 91.4 Million by …
The global sheep shearing equipment market was valued at US$ 755.8 Mn in 2022. The market is expected to develop from US$ 780 Mn in 2023 to US$ 1,069 Mn by 2033, registering a CAGR of 3.2% over the forecast period. Shearing machinery is used on farms to cut or remove wool from sheep's bodies. The exceptional qualities of this equipment have increased demand. The need for sheep shearing equipment is growing since regular shearing is necessary to keep
The UK Stock Tank Market was valued at US$ 499.2 Million by the time of 2033
A CAGR of 6.5% is predicted for the global stock tank market over the forecast period. The market is anticipated to increase from US$ 2.82 Bn in 2023 to US$ 5.30 Bn by 2033. The stock tank business has recently seen tremendous demand. The summer has grown more challenging for both humans and animals due to global warming. To save the farm animals and combat the heat, farms are installing stock tank pools significantly. Increasing demands for increased
By 2032, the Egg Albumin Protein Market is expected to be worth US$ 2.88 Billion
According to a recent report published by Future Market Insights, sales of egg albumin protein are estimated to reach a valuation of US$ 2.88 Bn by 2032, surging at 7.3% CAGR during the forecast period of 2022 to 2032. Egg albumin protein is absorbed by the blood and is used to separate proteins. It is expected to gain high popularity across the globe, especially in the sports nutrition sector owing to its ability

All 5 Releases


More Releases for Pharmaceuticals

Opioid Use Disorder Market ||Indivior, Alkermes, Titan Pharmaceuticals, Hikma Ph …
Zion Market Research published a new 110+ pages industry research “Opioid Use Disorder Market by Drug (Buprenorphine, Methadone and Naltrexone) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025” is exhaustively researched and analyzed in the report to help market players to improve their business tactics and ensure long-term success. The authors of the report have used easy-to-understand language and uncomplicated statistical images but provided thorough information and detailed data
Global Halal Pharmaceuticals Market 2019 - CCM Pharmaceuticals, Pharmaniaga, Ros …
This new report by Eon Market Research, titled “Global Halal Pharmaceuticals Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Halal Pharmaceuticals industry at a global as well as regional and country level. Key facts analyzed in this report include the Halal Pharmaceuticals market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study
Topical Antibiotic Pharmaceuticals Market 2016-2026 | Teva Pharmaceuticals, Perr …
Topical antibiotics are applied to a certain area of the skin to kill infections. Application of topical antibiotics has a number of advantages upon comparison of systemic delivery in the treatment of skin infections. Skin and soft tissue infections (SSTIs) involve microbial invasion of the skin and underlying soft tissues infections are one of the most commonly occurring conditions amongst people. Most of these infections are minor and chronic in
Lipid Disorder Treatment Market to 2017 - 2026: Teva Pharmaceuticals, Mylan Phar …
Researchmoz added Most up-to-date research on "Lipid Disorder Treatment Market - Global Industry Analysis, Share, Size, Growth, Trends and Forecast 2017 - 2026" to its huge collection of research reports Extensive research report on global lipid disorders treatment market skilfully crafted by Transparency Market Research depicts the current as well as future scenario of various drugs used to treat lipid disorders. The research study includes analysis on key developments that are
Halal Pharmaceuticals 2018 Global Market Key Players -CCM Pharmaceuticals, Pharm …
Halal Pharmaceuticals Market 2018 Wiseguyreports.Com Adds “Halal Pharmaceuticals – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Description:  In this report, the global Halal Pharmaceuticals market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions,
Global Wilson's Disease Market 2017- Valeant Pharmaceuticals International, Meda …
The Global Wilson's Disease Market 2017 Research Report includes a complete and meticulous study of Wilson's Disease industry covering different aspects like market volume, market Share, market strategies, Wilson's Disease growth trends, variety of applications, utilization volume, demand and supply analysis, production capacity and Wilson's Disease industry cost structures during Forecast period from 2017 to 2022. The report titled Global Wilson's Disease Market 2017 provides the comprehensive study of Wilson's Disease